Brief: BELLUS Health Reports Year 2020 Financial Results
25/02/2021 21:22
Feb 25 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH REPORTS YEAR 2020 FINANCIAL RESULTS AND
BUSINESS
HIGHLIGHTS
* BELLUS HEALTH - TOPLINE RESULTS EXPECTED Q4 2021 WITH AN
INTERIM ANALYSIS EXPECTED IN MID-2021 FOR SOOTHE CLINICAL TRIAL
IN REFRACTORY CHRONIC COUGH
* BELLUS HEALTH - TOPLINE RESULTS EXPECTED Q4 2021 FOR
PHASE 2
BLUEPRINT CLINICAL TRIAL
* BELLUS HEALTH INC - CURRENT CASH POSITION EXPECTED TO BE
SUFFICIENT TO FUND OPERATING PLAN UNTIL END OF 2022
Source text for Eikon: ID:nBw2GVfS9a
Further company coverage: BLU.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln